Real-time enrollment status for this chronic inducible urticaria clinical trial
Current Status
Recruiting
Checked: October 21, 2026 at 10:08 PM UTC
| NCT Number | NCT07266402 |
| Recruiting Status | Recruiting |
| Condition | Chronic Inducible Urticaria |
| Phase | PHASE3 |
| Target Enrollment | 240 participants |
| Active Locations | 26 sites in the US |
| Sponsor | Celldex Therapeutics |
| Last Updated on CT.gov | October 7, 2026 (2 weeks ago) |
As of October 21, 2026: Clinical trial NCT07266402 is currently recruiting participants. This phase3 study for chronic inducible urticaria is actively seeking new participants at 26 locations across the United States. The study is sponsored by Celldex Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07266402 is actively recruiting participants as of October 21, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 26 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07266402 was last updated 2 weeks ago (October 7, 2026). HelloStudys verifies this status automatically.